About this Journal Submit a Manuscript Table of Contents
Gastroenterology Research and Practice
Volume 2014 (2014), Article ID 342986, 6 pages
http://dx.doi.org/10.1155/2014/342986
Research Article

Impact of Rechallenge with Imatinib in Patients with Advanced Gastrointestinal Stromal Tumor after Failure of Imatinib and Sunitinib

1Department of Gastroenterology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya-shi, Aichi 464-8681, Japan
2Digestive and General Surgery 2 Division, Niigata University Hospital, 754 Ichibancho, Asahimachidori, Chuo-ku, Niigata-shi, Niigata 951-8510, Japan
3Department of Cancer Chemotherapy, Hokkaido University Hospital, Cancer Center, Kita 14-jo Nishi 5-chome, Kita-ku, Sapporo-shi, Hokkaido 060-8648, Japan
4Department of Surgery, Osaka University, School of Medicine, 2-2 Yamadaoka, Suita-shi, Osaka 565-0871, Japan

Received 7 May 2013; Accepted 27 December 2013; Published 22 January 2014

Academic Editor: Paul Enck

Copyright © 2014 Akira Sawaki et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Akira Sawaki, Tatsuo Kanda, Yoshito Komatsu, and Toshirou Nishida, “Impact of Rechallenge with Imatinib in Patients with Advanced Gastrointestinal Stromal Tumor after Failure of Imatinib and Sunitinib,” Gastroenterology Research and Practice, vol. 2014, Article ID 342986, 6 pages, 2014. doi:10.1155/2014/342986